Tomoki Fukuyama Selected Research

Tomoki Fukuyama Research Topics

Disease

17	Hypersensitivity (Allergy) 10/2021 - 06/2009
11	Inflammation (Inflammations) 01/2022 - 01/2010
11	Dermatitis 10/2021 - 09/2015
4	Atopic Dermatitis (Atopic Eczema) 01/2022 - 01/2018
4	Lung Injury 12/2021 - 01/2010
3	Immune System Diseases (Immune Disorders) 12/2020 - 11/2010
2	Allergic Contact Dermatitis 10/2021 - 01/2017
2	Asthma (Bronchial Asthma) 01/2021 - 07/2009
2	Pneumonia (Pneumonitis) 11/2020 - 11/2010
2	Pruritus (Itching) 01/2017 - 10/2015
2	Neoplasms (Cancer) 11/2016 - 01/2010
2	Hypertrophy 03/2015 - 03/2006
2	Autoimmune Diseases (Autoimmune Disease) 04/2013 - 03/2010
2	Peptic Ulcer (Peptic Ulcers) 09/2012 - 11/2010
2	Fibrosis (Cirrhosis) 11/2010 - 03/2006
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2020
1	Neural Tube Defects (Exencephaly) 01/2019
1	Megaloblastic Anemia 01/2019
1	Skin Diseases (Skin Disease) 01/2017
1	Mucositis 01/2017
1	Deglutition Disorders (Dysphagia) 01/2017
1	Stomatitis 01/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2017
1	Necrosis 03/2015
1	Carcinogenesis 04/2013
1	Communicable Diseases (Infectious Diseases) 04/2013
1	Anemia 01/2013
1	Dyspepsia (Indigestion) 10/2012

Drug/Important Bio-Agent (IBA)

5	Janus Kinase InhibitorsIBA 10/2021 - 09/2015
5	HaptensIBA 10/2021 - 10/2018
5	AllergensIBA 01/2021 - 05/2010
5	trimellitic anhydrideIBA 04/2019 - 06/2009
4	OrganophosphatesIBA 04/2019 - 07/2009
4	Interleukin-6 (Interleukin 6)IBA 01/2013 - 04/2009
3	Immunoglobulin E (IgE)IBA 01/2022 - 05/2010
3	Estrogen ReceptorsIBA 10/2020 - 01/2018
3	Methoxychlor (Metox)IBA 04/2019 - 08/2014
3	Dinitrochlorobenzene (DNCB)IBA 01/2019 - 05/2010
3	CytokinesIBA 10/2018 - 05/2010
3	tofacitinibIBA 01/2018 - 09/2015
3	oclacitinibIBA 01/2017 - 09/2015
2	deoxynivalenolIBA 01/2021 - 12/2020
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2020 - 01/2019
2	Benzo(a)pyreneIBA 11/2020 - 01/2019
2	Interleukin-33IBA 11/2020 - 01/2019
2	Parathion (Ethyl Parathion)IBA 04/2019 - 08/2014
2	AntipruriticsIBA 01/2019 - 09/2015
2	2,3-bis(4-hydroxyphenyl)-propionitrileIBA 01/2019 - 01/2018
2	NAD (NADH)IBA 01/2019 - 01/2018
2	bisphenol AIBA 01/2019 - 10/2018
2	AntioxidantsIBA 12/2016 - 01/2010
2	LipopolysaccharidesIBA 03/2015 - 01/2013
2	DDTIBA 03/2015 - 01/2013
2	Pharmaceutical PreparationsIBA 03/2015 - 11/2010
2	Chlorinated HydrocarbonsIBA 08/2014 - 06/2011
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2012 - 11/2010
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2012 - 11/2010
2	didecyldimethylammonium (didecyldimethylammonium chloride)IBA 07/2011 - 11/2010
2	Macrophage Migration-Inhibitory FactorsIBA 11/2010 - 08/2010
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Glucosylceramides (Glucocerebrosides)IBA 01/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	OzoneIBA 12/2021
1	Mastic ResinIBA 10/2021
1	Biological ProductsIBA 10/2021
1	MycotoxinsIBA 12/2020
1	LigandsIBA 11/2020
1	Imiquimod (Aldara)FDA LinkGeneric 10/2020
1	Interleukin-23 (Interleukin 23)IBA 10/2020
1	PeriostinIBA 01/2020
1	Peptides (Polypeptides)IBA 05/2019
1	neuromedin BIBA 05/2019
1	Agrochemicals (Agricultural Chemicals)IBA 04/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	Hypochlorous Acid (Hypochlorite)IBA 01/2018
1	IgE Receptors (Fc epsilon RI)IBA 12/2016
1	p-Methoxy-N-methylphenethylamineIBA 12/2016
1	PorphyrinsIBA 12/2016
1	ManganeseIBA 12/2016
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 11/2016
1	Janus KinasesIBA 09/2015
1	InsecticidesIBA 08/2014
1	Piperonyl Butoxide FDA Link 08/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2014
1	OvalbuminIBA 08/2014
1	Glutaral (Glutaraldehyde)IBA 01/2014
1	XenobioticsIBA 04/2013
1	IronIBA 01/2013
1	MicroRNAs (MicroRNA)IBA 10/2012
1	Local Anti-Infective Agents (Antiseptics)IBA 11/2010

Therapy/Procedure

5	Oral Administration 12/2020 - 10/2018
1	Topical Administration 01/2018
1	Particle Accelerators 01/2017
1	Chemoradiotherapy 01/2017
1	Radiotherapy 01/2017
1	Bite Force (Occlusal Forces) 01/2017